Tracked deals
4
4 tracked deals across 2020-2026.
Operating Company
Healthcare
Everest Clinical Research
Toronto, Ontario, Canada
Full-service contract research organization (CRO) providing expertise-based clinical research services to pharmaceutical, biotechnology, and medical device companies. Services include biostatistics, statistical programming, clinical data management, and end-to-end clinical trial services.
- Focus Areas
- Contract Research Organization (CRO), Biostatistics, Clinical Data Management
- Website
- everestclinical.com
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Addon
2 addon · 2 buyout
Everest Clinical Research Acquisition Volume by Year
Last 4 years
Actual
Full-year estimate
Supporting Data
Recent Transactions
-
September 17, 2026
- Buyer
- Everest Clinical Research, Arlington Capital Partners
- Target
- Firma Clinical Research (Biometrics and Data Services business unit)
- Seller
- Firma Clinical Research
- Industry
- Healthcare Services
- Location
- Ontario, Canada
- Type
- Buyout
Everest Clinical Research (“Everest”) announced the acquisition of the Biometrics and Data Services business unit of Firma Clinical Research (“Firma DS”). The deal expands Everest’s global biometrics expertise and clinical data science capabilities, adding an experienced biometrics team and supporting clients across the clinical development lifecycle.
-
November 7, 2023
- Buyer
- Everest Clinical Research, Arlington Capital Partners
- Target
- August Research
- Industry
- Healthcare Services
- Location
- Sofia City Province, Bulgaria
- Type
- Addon
Everest Clinical Research, a portfolio company of Arlington Capital Partners, has acquired European contract research organization August Research. The deal expands Everest's European footprint and clinical trial (CTS) and pharmacovigilance (PV) capabilities across 14 countries; August's founders will remain with the business. Financial terms were not disclosed.
-
December 2, 2022
- Buyer
- Everest Clinical Research, Arlington Capital Partners
- Target
- Brightech International
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Type
- Addon
Everest Clinical Research, a PE-backed full-service contract research organization, has acquired Brightech International, a specialist CRO focused on biostatistics, statistical programming, and clinical data management. The deal strengthens Everest's biometrics capabilities and global footprint, complementing its therapeutic strengths in Oncology, CNS, and Immunology.
-
December 7, 2020
- Buyer
- Arlington Capital Partners, Everest founding shareholders and senior management
- Target
- Everest Clinical Research Corporation
- Industry
- Healthcare Services
- Location
- Ontario, Canada
- Type
- Buyout
Washington, D.C.-based private equity firm Arlington Capital Partners has made a majority investment in Toronto-headquartered Everest Clinical Research Corporation, with Everest's founding shareholders and senior management rolling equity and continuing to lead the company. Everest is a full-service contract research organization (CRO) with ~300 employees across Toronto, Little Falls (NJ) and Shanghai; Arlington will support expansion of service lines, capabilities and headcount to drive growth.
Related Acquisition Pages
Selling a company? Get in front of buyers like Everest Clinical Research
Turn tracked acquisition activity into an outreach-ready buyer list.